Page last updated: 2024-08-23

zidovudine and Escherichia coli Infections

zidovudine has been researched along with Escherichia coli Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Baron, SA; Ben Khedher, M; Diene, SM; Peyclit, L; Rolain, JM; Zerrouki, L1
Jia, Y; Li, R; Liu, Y; Wang, Z; Xiao, X; Yang, K1
Keith, BR; White, G; Wilson, HR1

Other Studies

3 other study(ies) available for zidovudine and Escherichia coli Infections

ArticleYear
Inactivation of thymidine kinase as a cause of resistance to zidovudine in clinical isolates of Escherichia coli: a phenotypic and genomic study.
    The Journal of antimicrobial chemotherapy, 2020, 06-01, Volume: 75, Issue:6

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genomics; Humans; Microbial Sensitivity Tests; Thymidine Kinase; Zidovudine

2020
Anti-HIV agent azidothymidine decreases Tet(X)-mediated bacterial resistance to tigecycline in Escherichia coli.
    Communications biology, 2020, 04-03, Volume: 3, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-HIV Agents; Disease Models, Animal; Drug Synergism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Expression Regulation, Bacterial; Mice; Microbial Sensitivity Tests; Microbial Viability; Peritonitis; Tetracycline; Tetracycline Resistance; Zidovudine

2020
In vivo efficacy of zidovudine (3'-azido-3'-deoxythymidine) in experimental gram-negative-bacterial infections.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:4

    Topics: Ampicillin; Animals; Bacterial Infections; Cattle; Escherichia coli Infections; Female; Gram-Negative Bacteria; Mice; Mice, Inbred BALB C; Pyelonephritis; Salmonella Infections; Trimethoprim; Zidovudine

1989